Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9045435 Quinazoline compounds as sodium channel blockers

Patent 9045435 was granted and assigned to Purdue Pharma on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834447 Indole derivatives and use thereof
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+435 characters)
Article

Patent abstract

The invention relates to aryl substituted quinazolines of Formula I, and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein G, A, and R1-R4 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.

Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09045435 Quinazoline compounds as sodium channel blockers US Patent 9045435 Quinazoline compounds as sodium channel blockers

Infobox
Patent Number
0904543500
Patent Number
904543500
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0904543500
Edits on 23 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Purdue Pharma
Purdue Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090454350
Date of Patent
June 2, 2015
0
Patent Application Number
138780040
Date Filed
October 5, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090454350
Patent Primary Examiner
‌
Paul V Ward
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Purdue Pharma
Purdue Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090454350
Date of Patent
June 2, 2015
0
Patent Application Number
138780040
Date Filed
October 5, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090454350
Patent Primary Examiner
‌
Paul V Ward
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09045435
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09045435 Quinazoline compounds as sodium channel blockers

Infobox
Is a
Patent
Patent
Current assignee
Purdue Pharma
Purdue Pharma
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09045435
Date of patent
June 2, 2015
Patent application number
13878004
Date Filed
October 5, 2011
Patent primary examiner
‌
Paul V Ward

Find more entities like US Patent 9045435 Quinazoline compounds as sodium channel blockers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.